The predictive value of Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy
As a clinically accessible blood indicator, NPS has vital value in predicting the prognosis of resected locally advanced NSCLC patients receiving neoadjuvant chemotherapy and surgery.
Authors
- Yang Wang (ORCID: https://orcid.org/0000-0002-2582-7480)
- Chunyan Tang (ORCID: https://orcid.org/0000-0002-0073-6363)
- Jingjing Li (ORCID: https://orcid.org/0000-0003-0600-7097)
- Qi Li (ORCID: https://orcid.org/0000-0001-9660-7875)
- Shixuan Li (ORCID: https://orcid.org/0000-0003-3532-8789)
- Fangchao Li (ORCID: https://orcid.org/0009-0001-5018-4843)
- Min Yang (ORCID: https://orcid.org/0000-0001-9487-6828)
- Yanfei Zhang (ORCID: https://orcid.org/0009-0002-9211-3952)
Institutions
- Weifang Medical University (CN)
- University of Chicago Medical Center (US)
- Second Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.3389/fimmu.2025.1578896
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Natural Science Foundation of China
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Weifang Medical University